Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases

Autor: Trygve Syversveen, Harald Grut, Tor Magnus Smedman, Pål-Dag Line, Lars H. Jørgensen, Svein Dueland, Bård I. Røsok
Rok vydání: 2021
Předmět:
Zdroj: Transplant International. 34:2205-2213
ISSN: 1432-2277
0934-0874
DOI: 10.1111/tri.13995
Popis: Liver transplantation (LT) in selected colorectal cancer (CRC) patients with nonresectable liver-only metastases may result in 5-year overall survival of up to about 70-100%. However, the majority will have recurrent disease. All patients included in this report were included in prospective studies. Forty-four out of 56 patients had a relapse, and all 44 patients received treatment for recurrent disease. The organ of the first relapse was lung metastases in 23 of the 44 patients. The first treatment modality of the relapse was the treatment with curative intent in 55.8% of the patients, and chemotherapy was the first treatment administered to 25.6% of the patients. Patients receiving surgery of lung metastases had a 5-year overall survival of 66.5% from the time of metastasectomy. Patients receiving treatment with curative intent for metastases to other organs had a 5-year overall survival of 24.8%. Nine of the 44 patients had no evidence of disease (NED) at the end of the follow-up. Median time of NED in these patients was 54.3 months, and median overall survival from the time of LT was 8.4 years. Because of the high incidence of recurrent disease, these patients should have a systematic long-term follow-up since many of the relapses may be treated with curative intent.
Databáze: OpenAIRE
Externí odkaz: